Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil vs Standard Haemostatic Treatment in Cardiovascular Surgery
NCT00440401Phase 4Completed
- Sponsor
- Nycomed
- Start
- Feb 2007
- Primary completion
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tachosil in postoperative hemorrhage, sponsored by Nycomed. Started Feb 2007; status: completed.
02
Drugs
tachosil
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT00440401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440401.